{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_001130506.4:c.1309C>T",
          "cDNA Change": {
            "transcript": "NM_001130506.4",
            "ref": "C",
            "alt": "T",
            "position": "1309"
          },
          "Protein Change": {
            "ref": "W",
            "alt": "X",
            "position": "437"
          },
          "Description in input context": "homozygous W437X nonsense mutation"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson disease",
    "MONDO": "MONDO:0005163"
  },
  "Experiment Method": [
    {
      "Assay Method": "Mitochondrial respiratory function analysis",
      "Material used": {
        "Material Source": "Fibroblasts",
        "Material Name": "Patient-derived and control fibroblasts",
        "Description": "Fibroblasts from patients with PINK1 mutation and healthy controls were used."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130506.4:c.1309C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss-of-function",
          "Result Description": "Reduced mitochondrial respiratory activity, altered respiratory control ratio, and increased reliance on glycolysis for ATP production in patient fibroblasts compared to controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly stated in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly stated in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly stated in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly stated in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Standard mitochondrial respiratory activity (e.g., ATP production via oxidative phosphorylation) in healthy controls.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant reduction in respiratory activity and altered respiratory control ratio compared to healthy controls.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cytochrome c content and oxidase activity measurement",
      "Material used": {
        "Material Source": "Fibroblasts",
        "Material Name": "Patient-derived and control fibroblasts",
        "Description": "Fibroblasts from patients with PINK1 mutation and healthy controls were used."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130506.4:c.1309C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss-of-function",
          "Result Description": "Reduced cytochrome c content and decreased cytochrome c oxidase activity in patient fibroblasts compared to controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly stated in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly stated in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly stated in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly stated in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Standard cytochrome c content and oxidase activity in healthy controls.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant reduction in cytochrome c content and oxidase activity compared to healthy controls.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Reactive oxygen species (ROS) measurement",
      "Material used": {
        "Material Source": "Fibroblasts",
        "Material Name": "Patient-derived and control fibroblasts",
        "Description": "Fibroblasts from patients with PINK1 mutation and healthy controls were used."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130506.4:c.1309C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss-of-function",
          "Result Description": "Increased ROS levels in patient fibroblasts compared to controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly stated in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly stated in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly stated in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly stated in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Standard ROS levels in healthy controls.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significantly elevated ROS levels compared to healthy controls.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}